Vaccination campaigns in the U.S. and some other countries are moving from mass demand to more targeted efforts to reach the hesitant — and doctors want easier ways to deliver shots.
For months, developed economies have hoarded COVID-19 vaccines and the raw materials needed to make them. Now, they’re being forced to act as an explosive outbreak in India raises the risk of new virus mutations that could threaten the wider world.
President Biden far surpassed his original goal of administering 100 million doses of the COVID-19 vaccines within his first 100 days in office, but the initiative couldn’t have succeeded without a substantial manufacturing and logistics infrastructure backing it up.
The new focus — those who have been unable to sign up, are waiting to get a shot, or who have been reluctant or refused to be vaccinated — is a goal that requires different tactics involving smaller, more focused distribution.
A hacking campaign that IBM Corp. detected last year against organizations involved in the manufacturing, transportation and storage of COVID-19 vaccines was wider than initially understood and is now found to have targeted more than 40 companies in 14 countries, the company said Wednesday.
The latest supply-chain news, analysis, trends and tools for executives in the pharmaceutical and biotech industries. Learn how pharmaceutical and biotech companies and their suppliers around the world are managing the flow of products across all channels of the enterprise. Experts sound off on forecasting and demand planning, supply-chain visibility, logistics outsourcing, inventory optimization, transportation management, warehouse management, supply-chain security, corporate social responsibility and more.
Subscribe to our Daily Newsletter!
Timely, incisive articles delivered directly to your inbox.